Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise.
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds winknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from winknews.com Daily Mail and Mail on Sunday newspapers.
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds airdriecityview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from airdriecityview.com Daily Mail and Mail on Sunday newspapers.
Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise. The program allows the FDA to
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’